1. Academic Validation
  2. Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors

Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors

  • Eur J Med Chem. 2015 Aug 28:101:573-83. doi: 10.1016/j.ejmech.2015.07.011.
Daniela De Lucia 1 Oscar Méndez Lucio 2 Biagia Musio 3 Andreas Bender 4 Monika Listing 5 Sophie Dennhardt 6 Andreas Koeberle 7 Ulrike Garscha 8 Roberta Rizzo 9 Stefano Manfredini 10 Oliver Werz 11 Steven V Ley 12
Affiliations

Affiliations

  • 1 Department of Life Sciences and Biotechnology, University of Ferrara, Via L. Borsari 46, 44100 Ferrara, Italy; Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK. Electronic address: daniela.delucia@unife.it.
  • 2 Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK. Electronic address: om268@cam.ac.uk.
  • 3 Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK. Electronic address: bm450@cam.ac.uk.
  • 4 Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK. Electronic address: ab454@cam.ac.uk.
  • 5 Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, University of Jena, Philosophenweg 14, 07743 Jena, Germany. Electronic address: Monika.Listing@uni-jena.de.
  • 6 Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, University of Jena, Philosophenweg 14, 07743 Jena, Germany. Electronic address: Sophie.Dennhardt@uni-jena.de.
  • 7 Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, University of Jena, Philosophenweg 14, 07743 Jena, Germany. Electronic address: Andreas.Koeberle@uni-jena.de.
  • 8 Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, University of Jena, Philosophenweg 14, 07743 Jena, Germany. Electronic address: Ulrike.Garscha@uni-jena.de.
  • 9 Department of Medical Sciences, University of Ferrara, Via Fossato di Mortara 74, 44100, Ferrara, Italy. Electronic address: roberta.rizzo@unife.it.
  • 10 Department of Life Sciences and Biotechnology, University of Ferrara, Via L. Borsari 46, 44100 Ferrara, Italy. Electronic address: stefano.manfredini@unife.it.
  • 11 Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, University of Jena, Philosophenweg 14, 07743 Jena, Germany. Electronic address: Oliver.Werz@uni-jena.de.
  • 12 Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK. Electronic address: svl1000@cam.ac.uk.
Abstract

In this work the synthesis, structure-activity relationship (SAR) and biological evaluation of a novel series of triazole-containing 5-lipoxygenase (5-LO) inhibitors are described. The use of structure-guided drug design techniques provided compounds that demonstrated excellent 5-LO inhibition with IC50 of 0.2 and 3.2 μm in cell-based and cell-free assays, respectively. Optimization of binding and functional potencies resulted in the identification of compound 13d, which showed an enhanced activity compared to the parent bioactive compound caffeic acid 5 and the clinically approved zileuton 3. Compounds 15 and 16 were identified as lead compounds in inhibiting 5-LO products formation in neutrophils. Their interference with Other targets on the arachidonic acid pathway was also assessed. Cytotoxicity tests were performed to exclude a relationship between cytotoxicity and the increased activity observed after structure optimization.

Keywords

5-Lipoxygenase inhibitor; Caffeic acid; Inflammation; Polyphenol; Triazole; Zileuton.

Figures